Wire · opportunities
Beta Bionics Mint Patch Pump Gets FDA Clearance
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 22 September 2026 · Fusion42 review
Beta Bionics received FDA clearance for its Mint patch insulin pump, set to launch in the US in early 2027 with pharmacy channel distribution and significant insured population access. The tubeless, smartphone-controlled pump offers a novel alternative in insulin delivery and complements ongoing FDA review of Beta Bionics' separate 3D Intelligence dosing algorithm.
This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 14 Sep 2026 and 22 Sep 2026.
◆ ◆ The Wire takeaway
You face a new competitor redefining insulin delivery with a pharmacy-based, tubeless patch pump that bypasses traditional pump channels. Access via pharmacy benefits makes reimbursement and clinician trust urgent levers for market entry now.
◆ Coverage
2 sources · first reported 14 Sep 2026 · latest 22 Sep 2026
◆ Related on Wire
◆ Topics